Non-antibiotic treatments for bacterial diseases in an era of progressive antibiotic resistance

24Citations
Citations of this article
110Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The emergence of multi-drug resistant (MDR) microbial pathogens threatens the very foundation upon which standard antibacterial chemotherapy is based. We must consider non-antibiotic solutions to manage invasive bacterial infections. Transition from antibiotics to non-traditional treatments poses real clinical challenges that will not be easy to solve. Antibiotics will continue to reliably treat some infections (e.g., group A streptococci and Treponema pallidum) but will likely need adjuvant therapies or will need to be replaced for many bacterial infections in the future.

Cite

CITATION STYLE

APA

Opal, S. M. (2016, December 16). Non-antibiotic treatments for bacterial diseases in an era of progressive antibiotic resistance. Critical Care. BioMed Central Ltd. https://doi.org/10.1186/s13054-016-1549-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free